Tetrabuthylammonium

Tetrabuthylammonium

SCHEMBL237070

CCCC[N+](CCCC)(CCCC)CCCC.OCc1cccc(N2CCCC2)c1.[F-]

nearest known ligand 0.48

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRMT6 Q96LA8 1/20 0.48
AGXT P21549 2/20 0.46
KDM4E B2RXH2 2/20 0.41
MEN1 O00255 2/20 0.41
ALDH1A1 P00352 2/20 0.41
HPGD P15428 2/20 0.41
KMT2A Q03164 2/20 0.41
USP2 O75604 1/20 0.41
POLB P06746 1/20 0.41
MAPT P10636 1/20 0.41
BLM P54132 1/20 0.41
L3MBTL3 Q96JM7 2/20 0.40
L3MBTL1 Q9Y468 2/20 0.40
MBTD1 Q05BQ5 1/20 0.40
TP53BP1 Q12888 1/20 0.40
ALOX5 P09917 1/20 0.40
CFTR P13569 1/20 0.40
HTR7 P34969 1/20 0.39
GAA P10253 1/20 0.38
HSD17B10 Q99714 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3960459 0.83 AGXT (0.62) PRMT6AGXTKDM4EMEN1ALDH1A1
SCHEMBL6268645 0.81 PRMT6 (0.63) PRMT6AGXTKDM4EMEN1ALDH1A1
SCHEMBL28216220 0.80 AGXT (0.57) PRMT6AGXTKDM4EMEN1ALDH1A1
SCHEMBL10244433 0.74 PRMT6 (0.61) PRMT6AGXTKDM4EMEN1ALDH1A1
SCHEMBL24026846 0.73 CHKA (0.68) PRMT6AGXTALOX5HTR7CHKA
SCHEMBL166575 0.73 PRMT6 (0.65) PRMT6AGXTKDM4EMEN1ALDH1A1
SCHEMBL11891932 0.72 AGXT (0.65) PRMT6AGXTALOX5CFTRHTR7
SCHEMBL4480384 0.72 PRMT6 (0.68) PRMT6AGXTKDM4EMEN1ALDH1A1
SCHEMBL19601451 0.70 PRMT6 (0.57) PRMT6AGXTKDM4EMEN1ALDH1A1
SCHEMBL4806907 0.70 AGXT (0.58) PRMT6AGXTKDM4EMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2401276-A1 NITROGEN-CONTAINING FUSED HETEROCYCLIC COMPOUNDS AND THEIR USE AS BETA AMYLOID PRODUCTION INHIBITORS Eisai R&D Management Co., Ltd. (JP) 2012-01-04 EP disclosed
WO-2010098487-A1 NITROGEN-CONTAINING FUSED HETEROCYCLIC COMPOUNDS AND THEIR USE AS BETA AMYLOID PRODUCTION INHIBITORS EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-09-02 WO disclosed